SE301652B - - Google Patents

Info

Publication number
SE301652B
SE301652B SE1469364A SE1469364A SE301652B SE 301652 B SE301652 B SE 301652B SE 1469364 A SE1469364 A SE 1469364A SE 1469364 A SE1469364 A SE 1469364A SE 301652 B SE301652 B SE 301652B
Authority
SE
Sweden
Application number
SE1469364A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE301652B publication Critical patent/SE301652B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE1469364A 1963-12-06 1964-12-04 SE301652B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE301652B true SE301652B (xx) 1968-06-17

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (xx) 1963-12-06 1964-12-04
SE27767A SE304513B (xx) 1963-12-06 1967-01-09
SE27667A SE303507B (xx) 1963-12-06 1967-01-09

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE27767A SE304513B (xx) 1963-12-06 1967-01-09
SE27667A SE303507B (xx) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (xx)
AT (2) AT250348B (xx)
BE (1) BE656759A (xx)
CH (1) CH427803A (xx)
DE (1) DE1445848A1 (xx)
DK (4) DK106733C (xx)
ES (5) ES306817A1 (xx)
FR (2) FR1427775A (xx)
GB (1) GB1034939A (xx)
IL (1) IL22568A (xx)
NL (1) NL6414138A (xx)
SE (3) SE301652B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (xx) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
OA12413A (en) 2000-11-30 2004-09-30 Pfizer Prod Inc Combination of GABA agonists and aldose reductase inhibitors.
CZ20031399A3 (cs) 2000-11-30 2004-04-14 Pfizer Products Inc. Farmaceutický prostředek, kterým je směs agonistů gama-aminomáselné kyseliny a inhibitorů sorbitoldehydrogenázy
KR20060011873A (ko) * 2003-05-16 2006-02-03 화이자 프로덕츠 인코포레이티드 비정형 항정신약과 gaba 조절제, 항경련성 약물 또는 벤조다이아제핀의 치료 혼합물
EP1691811B1 (en) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2553291A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
AU2007249435A1 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
NL6414138A (xx) 1965-06-07
DK106796C (da) 1967-03-20
ES306819A1 (es) 1965-05-16
FR1427775A (fr) 1966-02-11
BE656759A (xx) 1965-06-08
GB1034939A (en) 1966-07-06
DK106733C (da) 1967-03-13
US3242190A (en) 1966-03-22
AT250348B (de) 1966-11-10
DK108169C (da) 1967-10-02
DK106797C (da) 1967-03-20
IL22568A (en) 1968-04-25
SE303507B (xx) 1968-09-02
CH427803A (de) 1967-01-15
SE304513B (xx) 1968-09-30
DE1445848A1 (de) 1968-11-21
ES306820A1 (es) 1965-05-16
AT249054B (de) 1966-09-26
FR4139M (xx) 1966-05-02
ES306818A1 (es) 1965-05-16
ES306816A1 (es) 1965-05-16
ES306817A1 (es) 1965-05-16

Similar Documents

Publication Publication Date Title
AR142945A1 (xx)
FR4139M (xx)
AT260747B (xx)
BE626358A (xx)
BE533484A (xx)
BE626590A (xx)
BE645618A (xx)
BE645320A (xx)
BE625880A (xx)
BE31062A (xx)
BE462764A (xx)
BE465565A (xx)
BE507458A (xx)
BE547422A (xx)
BE571209A (xx)
BE582314A (xx)
BE603935A (xx)
BE645041A (xx)
BE644983A (xx)
BE608372A (xx)
BE612803A (xx)
BE614220A (xx)
BE616247A (xx)
BE616830A (xx)
BE644842A (xx)